Chondroitin Sulfate Proteoglycan 4 (CSPG4) as an Emerging Target for Immunotherapy to Treat Melanoma.

Autor: Chen, Xinyi1 (AUTHOR) joanna.m.troka@kcl.ac.uk, Habib, Shabana1 (AUTHOR) avigail.rahimi@kcl.ac.uk, Alexandru, Madalina1 (AUTHOR) heather.bax@kcl.ac.uk, Chauhan, Jitesh1 (AUTHOR), Evan, Theodore1 (AUTHOR), Troka, Joanna M.1 (AUTHOR), Rahimi, Avigail1 (AUTHOR), Esapa, Benjamina1 (AUTHOR), Tull, Thomas J.1 (AUTHOR), Ng, Wen Zhe1 (AUTHOR), Fitzpatrick, Amanda1,2,3 (AUTHOR), Wu, Yin1,3,4 (AUTHOR), Geh, Jenny L. C.5,6 (AUTHOR), Lloyd-Hughes, Hawys6 (AUTHOR), Palhares, Lais C. G. F.1 (AUTHOR), Adams, Rebecca1 (AUTHOR), Bax, Heather J.1 (AUTHOR), Whittaker, Sean1 (AUTHOR), Jacków-Malinowska, Joanna1 (AUTHOR), Karagiannis, Sophia N.1,3 (AUTHOR) sophia.karagiannis@kcl.ac.uk
Zdroj: Cancers. Oct2024, Vol. 16 Issue 19, p3260. 22p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje